ACUTE: Serelaxin vs placebo
Hyperkalaemia · heart failure with chronic kidney disease
It is very uncertain whether ACUTE: Serelaxin changes hyperkalaemia compared with placebo (very low certainty).
1 finding from 1 review
- Pharmacological interventions for heart failure in people with chronic kidney disease 2020 · Cochrane Headline outcomes onlyRR 1.081 study · 234 participantsVery low